Alex­ion puts €65M for­ward to strength­en its po­si­tion on the Emer­ald Isle

Ire­land has been on a roll in 2022, with sev­er­al large phar­ma com­pa­nies an­nounc­ing mul­ti­mil­lion-eu­ro projects. Now As­traZeneca’s rare dis­ease out­fit Alex­ion is look­ing to get in on the ac­tion.

Alex­ion on Fri­day an­nounced a €65 mil­lion ($68.8 mil­lion) in­vest­ment in new and en­hanced ca­pa­bil­i­ties across two sites in the coun­try, in­clud­ing at Col­lege Park in the Dublin sub­urb of Blan­chard­stown and the Monksland In­dus­tri­al Park in the cen­tral Irish town of Athlone, ac­cord­ing to the In­dus­tri­al De­vel­op­ment Agency of Ire­land.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER